| Management target | Revenue 25.0% FY27 |
|---|
| Revenue growth | H1 grew 26% YoY, Q2 grew 24% YoY, driven by e-commerce volumes. |
|---|---|
| Margins | Sharp contraction from 48% to 31% due to ₹13.4 Cr branding burn. |
| Demand visibility | Strong house-hold reach through products; aiming for 7,000-10,000 beds in 3-5 years. |
| Management confidence | Humbled and apologetic regarding margin miss; pivoting back to service-first strategy. |
Growth
H1 revenue grew 26% YoY to ₹460 Cr, but Q2 margins collapsed to 31% from 48% due to branding costs.
Outlook
Management reiterated FY27 revenue targets of ₹1,000 Cr with restored EBITDA margins of 35-40% by Q4.
Risks
Reliance on low-margin e-commerce customer conversion and potential mark-to-market losses on equity investments like Chandan Healthcare.
Earnings Call Transcript filed with NSE, NSE: JSLL. Summary written with AI assistance from the document.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹294.75
- Market cap
- ₹3,664 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 17.1×Sector 48.6×
- Promoter holding
- 63.67%+0.05% QoQ
- FII holding
- 4.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Capacity Expansion
Jeena Sikho Lifecare began operations at a new 17,700 sq ft client support centre in Noida effective November 18, 2026. The facility expands its healthcare service network.
- client support centre area
- 17700.0 sq ft
Jeena Sikho Lifecare Q2 FY27 Results: Net Profit ₹36.6 Cr, Down 37.8% YoY
Jeena Sikho Lifecare Ltd reported revenue from operations of ₹235.1 Cr (+23.9% YoY) and net profit of ₹36.6 Cr (-37.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹36.6 Cr · -37.8% YoY
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
Jeena Sikho Lifecare Merger & Restructuring Worth ₹0.03 Cr
Jeena Sikho Lifecare's board approved incorporating Ayugenomics Private Limited as a subsidiary, holding 60%. The company will invest Rs 3 lakh, subject to statutory approvals.
- Value
- ₹0.03 Cr
Jeena Sikho Lifecare Board Meeting Date
Jeena Sikho Lifecare has scheduled a board meeting for 14 Nov 2026 to consider unaudited Q1 FY27 financial results. The trading window is closed from 1 Oct to 16 Nov 2026.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.